James H Varnell, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 346 Deep South Farm Rd Ste B, Blairsville, GA 30512 Phone: 770-534-2020 Fax: 770-534-8025 |
Dr. Megan Christine Smith, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 346 Deep South Farm Rd Ste B, Blairsville, GA 30512 Phone: 770-534-2020 Fax: 770-534-8025 |
Dr. Mary B Frankis, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 346 Deep South Farm Rd Ste B, Blairsville, GA 30512 Phone: 770-534-2020 Fax: 770-534-8025 |
Dr. Robert C Rollings, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 191 Deep South Farm Rd, Blairsville, GA 30512 Phone: 706-439-6380 |
John W Kelley, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 191 Deep South Farm Rd, Blairsville, GA 30512 Phone: 706-439-6380 Fax: 706-439-6398 |
Mr. Michael B Sabom, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 77 Weaver Road, Suite B, Blairsville, GA 30512 Phone: 706-835-1914 Fax: 706-835-1920 |
Katherine M Duello, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 191 Deep South Farm Rd, Blairsville, GA 30512 Phone: 706-439-6380 Fax: 706-439-6398 |
Dr. Mark Allen Gibson, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 191 Deep South Farm Rd, Blairsville, GA 30512 Phone: 706-439-6380 Fax: 706-439-6398 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced results from a 36-week active extension study evaluating two doses of laquinimod, an investigational, once-daily oral immunomodulator, for the treatment of relapsing remitting multiple sclerosis.
A team of scientists from I.M. Sechenov First Moscow State Medical University together with their colleagues isolated a peptide named emericellipsin A from soil fungi.
The World Health Organisation (WHO) is quite rightly patting itself on the back because it has persuaded as many as 13 drug companies to abandon the marketing and promotion of monotherapy in the treatment of Malaria.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December 31, 2013.
› Verified 2 days ago